Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorKahraman, S.
dc.contributor.authorErdim, R.
dc.contributor.authorHelvacioglu, F.
dc.contributor.authorDogan, A.
dc.contributor.authorSozer, V
dc.contributor.authorGunay, D.
dc.contributor.authorAytekin, V
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T15:56:03Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T15:56:03Z
dc.date.issued2018
dc.identifier.issn0006-9248
dc.identifier.issn1336-0345
dc.identifier.urihttps://dx.doi.org/10.4149/BLL_2018_071
dc.identifier.urihttp://hdl.handle.net/11446/2203
dc.descriptionWOS: 000436626500011en_US
dc.descriptionPubMed ID: 29947240en_US
dc.description.abstractOBJECTIVES: We aimed to associate a coronary artery disease (CAD) presence and severity with endothelial dysfunction (ED), carotid intima media thickness (CIMT) and Tissue Factor Pathway Inhibitor (TFPI). BACKGROUND: ED has a central role in atherosclerosis. CIMT and TFPI activity are also related with atherosclerosis and CAD. METHODS: In our prospective observational study, 50 patients had CAD and 30 had normal coronary arteries. Endothelial function was evaluated by endothelium-dependent flow-mediated dilatation (FMD) and nitroglycerinemediated dilatation (NMD) measurements. CIMT and Serum TFPI levels were also measured. RESULTS: TFPI was a statistically significant determinant between the two groups with an increased level in CAD (+) group (84.9 +/- 19.3 vs 70.2 +/- 14.7, p = 0.001). There was a positive correlation between CIMT and Gensini (r = 0.34, p = 0.014). There was a strong negative correlation between Gensini and FMD-NMD, statistically significant (FMD: r =-0.715, p < 0.001; NMD: r = -0.718, p < 0.001). CONCLUSION: We observed that ED, increased CIMT and TFPI levels were associated with CAD. Additionally, increased CIMT measurements and decreased FMD and NMD values had a positive correlation with GSS (Tab. 4, Fig. 6, Ref. 50). Text in PDF www.elis.sk.en_US
dc.language.isoengen_US
dc.publisherCOMENIUS UNIVen_US
dc.identifier.doi10.4149/BLL_2018_071en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectcoronary artery diseaseen_US
dc.subjectendothelial dysfunctionen_US
dc.subjecttissue factor pathway inhibitoren_US
dc.titleThe impact of TFPI on coronary atherosclerotic burdenen_US
dc.typearticleen_US
dc.relation.journalBRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTYen_US
dc.departmentDBÜen_US
dc.identifier.issue6en_US
dc.identifier.volume119en_US
dc.identifier.startpage385en_US
dc.identifier.endpage390en_US
dc.contributor.authorID0000-0002-4996-8165en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Kahraman, S. -- Erdim, R. -- Helvacioglu, F. -- Dogan, A. -- Sozer, V -- Gunay, D. -- Aytekin, S. -- Aytekin, V] Istanbul Bilim Univ, Fac Med, Dept Cardiol, Istanbul, Turkey -- [Erdim, R. -- Aytekin, S. -- Aytekin, V] Sisli Florence Nightingale Hosp, Dept Cardiol, Istanbul, Turkey -- [Sozer, V] Yildiz Tech Univ, Dept Biochem, Istanbul, Turkey -- [Gunay, D.] Sisli Florence Nightingale Hosp, Dept Biochem, Istanbul, Turkeyen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster